iothalamate-meglumine and Facial-Neoplasms

iothalamate-meglumine has been researched along with Facial-Neoplasms* in 1 studies

Trials

1 trial(s) available for iothalamate-meglumine and Facial-Neoplasms

Article	Year
Iopamidol and Conray 60: comparison in superselective angiography. Radiology, 1984, Volume: 152, Issue:3 Iopamidol (280 mgI/ml) was compared with Conray 60 (iothalmate meglumine, 282 mgI/ml) during selective and superselective cerebral arteriography. Twelve patients were examined, and a total of 51 selective injections were compared. Iopamidol produced significantly less pain and burning than Conray 60 and caused no patient motion. Topics: Adult; Aged; Cerebral Angiography; Clinical Trials as Topic; Double-Blind Method; Facial Neoplasms; Female; Hemangioma; Humans; Intracranial Arteriovenous Malformations; Iopamidol; Iothalamate Meglumine; Iothalamic Acid; Male; Meningeal Neoplasms; Meningioma; Middle Aged	1984

Article

Year

Iopamidol and Conray 60: comparison in superselective angiography.

Radiology, 1984, Volume: 152, Issue:3

Iopamidol (280 mgI/ml) was compared with Conray 60 (iothalmate meglumine, 282 mgI/ml) during selective and superselective cerebral arteriography. Twelve patients were examined, and a total of 51 selective injections were compared. Iopamidol produced significantly less pain and burning than Conray 60 and caused no patient motion.

Topics: Adult; Aged; Cerebral Angiography; Clinical Trials as Topic; Double-Blind Method; Facial Neoplasms; Female; Hemangioma; Humans; Intracranial Arteriovenous Malformations; Iopamidol; Iothalamate Meglumine; Iothalamic Acid; Male; Meningeal Neoplasms; Meningioma; Middle Aged

1984